Practical advice for travellers with immune disorders;Praktische adviezen voor reizigers met een afweerstoornis

Nederlands Tijdschrift voor Geneeskunde

Volumn 152, Issue 31, 2008, Pages 1725-1729

  Gelinck, L B S ^a   Roukens, A H E ^a   Kroon, F P ^a   Visser, L G ^a  

^a LEIDEN UNIVERSITY MEDICAL CENTER   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

LIVE VACCINE;

DRUG CONTRAINDICATION; HUMAN; IMMUNE DEFICIENCY; IMMUNOCOMPROMISED PATIENT; IMMUNOPATHOLOGY; INFECTION RISK; REVIEW; TRAVEL; VACCINATION;

ANTIBODY FORMATION; HUMANS; IMMUNOCOMPROMISED HOST; SEVERITY OF ILLNESS INDEX; TRAVEL; VACCINATION; VACCINES, ATTENUATED;

EID: 49749132763     PISSN: 00282162     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (38)

1. Committee to Advise on Tropical Medicine and Travel (CATMAT). The immunocompromised traveller. An Advisory Committee Statement (ACS). Can Commun Dis Rep. 2007;33(ACS-4):1-24.
2. Peetermans WE, Visser LG. Afweerstoornissen. In: Gompel AML van, Denekes JPM, redacteuren. Reizen en ziekte. Houten: Bohn Stafleu van Loghum; 2000. p. 158-68.
3. Dutch national guidelines on travelers' medicine. Amsterdam: Landelijk Coördinatiecentrum Reizigersadvisering; 2007.
4. Suh KN, Mileno MD. Challenging scenarios in a travel clinic: advising the complex traveler. Infect Dis Clin North Am. 2005;19:15-47.
5. Gelinck LBS, Teng YKO, Rimmelzwaan GF, Bemt BJF van den, Kroon FP, Laar JM van. Poor serological responses upon influenza vaccination in patients with rheumatoid arthritis treated with rituximab. Ann Rheum Dis. 2007;66:1402-3.
6. Vaccinations in the immunocompromised person. Guidelines for the patient taking immunosuppressants, steroids and the new biologic therapies. Londen: British Society for Rheumatology; 2002.
7. Stuck AE, Minder CE, Frey FJ. Risk of infectious complications in patients taking glucocorticosteroids. Rev Infect Dis. 1989;11:954-63.
8. Dissel JT van, Kroon FP. Voorkómen van levensbedreigende infecties bij personen zonder (functionele) milt. Nederlands Tijdschrift voor Hematologie. 2004;1:91-7.
9. Chotivanich K, Udomsangpetch R, McGready R, Proux S, Newton P, Pukrittayakamee S, et al. Central role of the spleen in malaria parasite clearance. J Infect Dis. 2002;185:1538-41.
10. Cobelens FG, Leentvaar-Kuijpers A, Kleijnen J, Coutinho RA. Incidence and risk-factors of diarrhoea in Dutch travelers: consequences for priorities in pre-travel health advice. Trop Med Int Health. 1998;3:896-903.
11. Kengsakul K, Sathirapongsasuti K, Punyagupta S. Fatal myeloencephalitis following yellow fever vaccination in a case with HIV infection. J Med Assoc Thai. 2002;85:131-4.
12. King SM, Saunders EF, Petric M, Gold R. Response to measles, mumps and rubella vaccine in paediatric bone marrow transplant recipients. Bone Marrow Transplant. 1996;17:633-6.
13. Eidex RB. History of thymoma and yellow fever vaccination. Yellow Fever Vaccine Safety Working Group. Lancet. 2004;364:936.
14. Khromava AY, Eidex RB, Weld LH, Kohl KS, Bradshaw RD, Chen RT, et al. Yellow fever vaccine: an updated assessment of advanced age as a risk factor for serious adverse events. Vaccine. 2005;23:3256-63.
15. Ottenhoff TH, Verreck FA, Lichtenauer-Kaligis EG, Hoeve MA, Sanal O, Dissel JT van. Genetics, cytokines and human infectious disease: lessons from weakly pathogenic mycobacteria and salmonellae. Nat Genet. 2002;32:97-105.
16. Günther M, Stark K, Neuhaus R, Reinke P, Schröder K, Bienzle U. Rapid decline of antibodies after hepatitis A immunization in liver and renal transplant recipients. Transplantation. 2001;71:477-9.
17. Arslan M, Wiesner RH, Poterucha JJ, Zein NN. Safety and efficacy of hepatitis A vaccination in liver transplantation recipients. Transplantation. 2001;72:272-6.
18. Kroon FP, Dissel JT van, Jong JC de, Zwinderman K, Furth R van. Antibody response after influenza vaccination in HIV-infected individuals: a 3-year consecutive study. Vaccine. 2000;18:3040-9.
19. Jaijaroensup W, Tantawichien T, Khawplod P, Tepsumethanon S, Wilde H. Postexposure rabies vaccination in patients infected with human immunodeficiency virus. Clin Infect Dis. 1999;28:913-4.
20. Chadwick DR, Geretti AM. Immunization of the HIV infected traveller. AIDS. 2007;21:787-94.
21. Panasiuk B, Prokopowicz D, Panasiuk A. Immunological response in HIV-positive patients vaccinated against tick-borne encephalitis. Infection. 2003;31:45-6.
22. Branigan EF, Stevenson MM, Charles D. Blood transfusion reaction in a patient with immunoglobulin A deficiency. Obstet Gynecol. 1983;61(3 Suppl):47S-9S.
23. Degoricija V, Sovic D, Pavlinovic N. Acute allergic posttransfusion reaction in a patient with immunoglobulin A deficiency. Lijec Vjesn. 2001;123:74-6.
24. Kumar ND, Sharma S, Sethi S, Singh RP. Anaphylactoid transfusion reaction with anti-IgA antibodies in an IgA deficient patient: a case report. Indian J Pathol Microbiol. 1993;36:282-4.
25. Miwa Y, Negishi M, Hanaoka R, Hatano Y, Iwabuchi H, Kanemitu H, et al. A case report of selective IgA deficiency in rheumatoid arthritis and anti-IgA antibody induced anaphylactic transfusion. Ryumachi. 1998;38:735-40.
26. Wei CH, Lin M, Hsieh RK, Tzeng CH, Liu JH, Fan S, et al. Selective IgA deficiency and anaphylactoid transfusion reaction: a case report. Zhonghua Yi Xue Za Zhi (Taipei). 1996;57:165-8.
27. Crance JM, Scaramozzino N, Jouan A, Garin D. Interferon, ribavirin, 6-azauridine and glycyrrhizin: antiviral compounds active against pathogenic flaviviruses. Antiviral Res. 2003;58:73-9.
28. Angell SY, Behrens RH. Risk assessment and disease prevention in travelers visiting friends and relatives. Infect Dis Clin North Am. 2005;19:49-65.
29. Ahmed QA, Arabi YM, Memish ZA. Health risks at the Hajj. Lancet. 2006;367:1008-15.
30. Bruyn G de, Hahn S, Berwick A. Antibiotic treatment for travellers' diarrhoea [Cochrane review]. Cochrane Database Syst Rev. 2000;(3):CD002242.
31. Committee to Advice on Tropical Medicine and Travel (CATMAT). An advisory committee statement (ACS). Statement on travellers' diarrhoea. Can Commun Dis Rep. 2001;27(ACS-3):1-12.
32. Isenbarger DW, Hoge CW, Srijan A, Pitarangsi C, Vithayasai N, Bodhidatta L, et al. Comparative antibiotic resistance of diarrheal pathogens from Vietnam and Thailand, 1996-1999. Emerg Infect Dis. 2002;8:175-80.
33. Neuvonen PJ, Olkkola KT. Oral activated charcoal in the treatment of intoxications. Role of single and repeated doses. Med Toxicol Adverse Drug Exp. 1988;3:33-58.
34. Boggild AK, Sano M, Humar A, Salit I, Gilman M, Kain KC. Travel patterns and risk behavior in solid organ transplant recipients. J Travel Med. 2004;11:37-43.
35. Roukens AHE, Dissel JT van, Fijter JW de, Visser LG. Health preparations and travel-related morbidity of kidney transplant recipients traveling to developing countries. Clin Transplant. 2007;21:567-70.
36. Jelinek T, Schulte C, Behrens R, Grobusch MP, Coulaud JP, Bisoffi Z, et al. Imported Falciparum malaria in Europe: sentinel surveillance data from the European network on surveillance of imported infectious diseases. Clin Infect Dis. 2002;34:572-6.
37. Matteelli A, Colombini P, Gulletta M, Castelli F, Carosi G. Epidemiological features and case management practices of imported malaria in northern Italy, 1991-1995. Trop Med Int Health. 1999;4:653-7.
38. Baas MC, Wetsteyn JC, Gool T van. Patterns of imported malaria at the Academic Medical Center, Amsterdam, the Netherlands. J Trav Med. 2006;13:2-7.